Next generation sequencing (NGS) of primary central nervous system tumors (CNST) as part of a personalized medicine cancer research program (PMRP) to identify alterations with sensitivity to targeted inhibitors.
2016 ◽
Vol 34
(15_suppl)
◽
pp. 2066-2066
2017 ◽
Vol 19
(suppl_6)
◽
pp. vi179-vi180
◽